• Explore /
  • Poster
  • / Genetic variants of ATM and XRCC3 to predict efficacy of TAS-102 in patients with refractory metastatic colorectal cancer.

Genetic variants of ATM and XRCC3 to predict efficacy of TAS-102 in patients with refractory metastatic colorectal cancer.

Abstract Poster

Authors

null

Mitsukuni Suenaga

Division of Medical Oncology, USC Norris Comprehensive Cancer Center, Los Angeles, CA

Mitsukuni Suenaga , Marta Schirripa , Shu Cao , Wu Zhang , Dongyun Yang , Martin D. Berger , Jordan David West , Yan Ning , Lisa Salvatore , Daniele Rossini , Carlotta Antoniotti , Ramu Inoue , Satoshi Matsusaka , Satoshi Okazaki , Yuji Miyamoto , Diana L. Hanna , Afsaneh Barzi , Fotios Loupakis , Heinz-Josef Lenz

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Colorectal) Cancer

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Epidemiology/Outcomes

Citation

J Clin Oncol 34, 2016 (suppl; abstr 3579)

DOI

10.1200/JCO.2016.34.15_suppl.3579

Abstract #

3579

Poster Bd #

276

Abstract Disclosures

Similar Posters

First Author: Wu Zhang

First Author: Mitsukuni Suenaga

First Author: Mitsukuni Suenaga

First Author: Anup Kasi